Soap-scented oil skin patch in the treatment of fibromyalgia: A case series by Ough, Yon Doo
© 2008 Ough, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which 
permits unrestricted noncommercial use, provided the original work is properly cited.
Journal of Multidisciplinary Healthcare 2008:1 59–62 59
CASE REPORT
Soap-scented oil skin patch in the treatment 
of f  ibromyalgia:   A case series
Yon Doo Ough
Department of Anesthesiology, Beloit 
Memorial Hospital, Beloit, WI, USA
Correspondence:   Yon Doo Ough
Department of Anesthesiology, Beloit 
Memorial Hospital, 1969 West Hart Road, 
Beloit, WI 53511, USA
Tel +1 608 364 5226
Fax +1 608 364 5227
Email yonough@gmail.com
Abstract: Treatment for fibromyalgia is largely empiric and supportive, and favors a 
multidisciplinary approach. Despite treatment, symptomatic relief is often inadequate and 
temporary. Over 90% of ﬁ  bromyalgia patients seek alternative medical care. There is much 
anecdotal evidence that applying a bar of soap to the skin can relieve leg cramps. Expanding 
on this idea, I created a skin patch from soap-scented oil, which was used to treat muscular 
pain and spasms. After receiving positive feedback from several patients, I hypothesized that 
the scent of the oil itself, applied directly to the skin, is responsible for the pain-relieving and 
muscle-relaxant properties of the skin patch. Furthermore, I hypothesize that this soap-scented 
oil skin patch is an effective treatment for the pain associated with ﬁ  bromyalgia.
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Introduction
Soap has existed for over 2,000 years. It is a ubiquitous and essential product for modern 
daily life. Except for its cleansing and antiseptic effects, no other medicinal beneﬁ  ts 
have been previously described in the medical literature (Wolf et al 2000).
There is much anecdotal evidence that applying a bar of soap to the skin can 
relieve leg cramps. In a popular newspaper column, Dr. Gott recommends the use of 
a bar of soap to prevent nocturnal leg cramps (Gott pers comm.), advising patients 
to sleep with a bar of soap between their legs. Following this example, I assembled 
a skin patch made of crushed bar soap, and achieved successful results in regards to 
relief of muscle cramping and pain. I further experimented with the use of this soap 
patch for various other painful medical conditions.
It was noted that the soap patch was successful in relieving pain from muscle 
cramps, knots, and even the trigger point pain associated with chronic myofascial pain 
syndrome. The soap patch also is effective for smooth muscle spasms, relieving the 
pain from menstrual cramps, intestinal cramps, and kidney stone.
Hypothesizing that the scent of the soap was the active ingredient responsible 
for alleviating pain, I have since assembled the skin patches with a soap-scented oil 
(SSO), rather than bar soap itself, and hope to continue to expand its applications to 
other disease states.
One such area of interest is ﬁ  bromyalgia. Fibromyalgia is a common, chronic, and 
complex disease that is deﬁ  ned as widespread musculoskeletal pain with multiple tender 
points. Patients with ﬁ  bromyalgia also tend to experience symptoms of depression, 
sleep disturbance and fatigue, as well as a poor quality of life and a high incidence 
of disability (Chakrabarty and Zoorob 2007). These patients also frequently report 
migraine headaches, and nearly 80% of this population rates them as severe, although 
many have not sought treatment for their symptoms (Marcus et al 2005).Journal of Multidisciplinary Healthcare 2008:1 60
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Treatment for fibromyalgia is largely empiric and 
supportive, and favors a multidisciplinary approach including 
psychotherapy, physical therapy, medication, exercise and 
behavioral therapy. Despite treatment, symptomatic relief 
is often inadequate and temporary (Millea and Holloway 
2000). Over 90% of ﬁ  bromyalgia patients seek alternative 
medical care, including acupuncture, herbal medicine, yoga 
and massage therapy (Berman et al 2000; Crofford and 
Appleton 2001).
I hypothesize that application of the SSO skin patch 
is an effective treatment for the pain associated with 
ﬁ  bromyalgia.
Materials
Soap-scented oil manufactured by Belle-Aire Fragrances, 
Inc. was used for this study. The components of this oil are 
citronellol, geraniol, camphor, eucalyptol, and thymol. There 
is no actual soap in the scented oil.
Due to the occasional skin irritant effects of undiluted 
scented oils (Foster and Johnson 2000; Weiss and Fintelmann 
2000), the SSO was diluted with castor oil to a ﬁ  nal concen-
tration of 5% SSO. Castor oil was originally chosen as the 
dilutent for the SSO because of its frequent use in the medical 
ﬁ  eld (McGarey 2004). All patches in this study were made 
using 5% SSO.
An impermeable surgical drape was used for the 
template of the patch, upon which a 4-inch by 3-inch 
absorbable sponge was centered. The sponge was soaked 
with 7 ml of 5% SSO, and ten minutes were allowed for 
absorption. The sponge was then covered with a sheet 
of adhesive tape. All completed SSO skin patches were 
stored in sealed plastic bags to prevent evaporation and 
dissipation of scent.
Methods
Eighty three patients with ﬁ  bromyalgia contacted me with 
a request to try the SSO skin patch. Among these patients, 
fourteen who reported consistently severe pain (pain score 
7 and higher) were selected for the study. They are all 
female, between the ages of 43 and 69 years old, (Table 1). 
All patients gave informed consent, and the study protocol 
conformed to the ethical guidelines of the 1964 Declaration 
of Helsinki.
A pain scale based on numeric ratings was used, deﬁ  ned 
as: 0 = no pain; 1–3 = mild pain; 4–6 = moderate pain; 
7–9 = severe pain; 10 = unbearable pain.
Results
All patients reported initial pain relief within one hour 
of application, including one patient who reported nearly 
immediate relief within three minutes. Three patients 
reported nearly complete relief of pain (rated 0–3), and the 
remainder reported pain levels of 4 or less. The pain relief 
lasted between 18 hours to 30 hours. Many patients also 
reported that nighttime application of the SSO skin patch 
gave the added beneﬁ  t of more restful sleep.
Table 1 Summary of patient responses to soap-scented oil skin patch treatment
Patient Age 
(years)
Duration of 
ﬁ  bromyalgia 
(years)
Length of time until 
maximum relief 
achieved following 
patch application
Headache Pre-treatment 
pain rating
Post-treatment 
pain rating
1 56 12 40 minutes No 8–10 2–3
2 48 2.5 1 hour Yes 8–10 0–3
3 67 45 20 minutes No 9–10 1–3
4 50 20 1–2 hours No 7–8 2–3
5 54 9 1–2 hours No 10 0–2
6 50 5 2 hours Yes 7–8 2–3
7 58 15 3 hours Yes 7 3
8 43 5 30 minutes Yes 8–9 1–2
9 56 23 3 minutes Yes 9 1
10 69 26 1–2 hours No 10 0–2
11 48 12 1–3 hours Yes 10 1–2
12 62 15 1 hour Yes 8–9 4
13 51 5 20 minutes No 10 1–3
14 53 8 1 hour No 8–9 1–2Journal of Multidisciplinary Healthcare 2008:1 61
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Seven patients studied also suffered from headaches and 
reported symptomatic relief within an hour when the SSO 
skin patch was applied to the back of the neck.
All patients were able to use the SSO skin patches without 
notable side effects.
Case report 1
The patient is a 56-year-old female with an 11-year history 
of ﬁ  bromyalgia. She described numerous, widespread tender 
points along her upper arms, shoulders and back, and her 
condition has diminished her quality of life. She has received 
treatment from her primary care physician, rheumatologist, 
psychiatrist, physical therapist and chiropractor. As a sleep 
aid, she was taking duloxetine hydrochloride (Cymbalta) 
20 mg and amitriptyline (Elavil) 25 mg.
After application of the SSO skin patch, the patient 
reported a pain score decrease from 8–10 to 2–3.
Case report 2
The patient is a 48-year-old female artist who has suffered 
from ﬁ  bromyalgia for nearly three years. She also reports 
headaches, up to three times a week, and has discontinued 
all medications, citing their inefﬁ  cacy. Unable to participate 
in social activities and enjoy her art, her severe pain (rated as 
high as 10) also left her with a resultant depression.
After application of the SSO skin patch, she reported 
satisfactory pain relief (rated 1–3) of both ﬁ  bromyalgia and 
headache, as well as improved quality of life.
Case report 3
The patient is a 67-year-old female with a 45-year history of 
ﬁ  bromyalgia. She spent most of her time indoors, usually in bed, 
due to her intense pain (rated 9–10). She also reports difﬁ  culty 
sleeping, in spite of pharmacological sleeping aids.
Within 20 minutes of SSO skin patch application, she 
reported nearly complete pain relief (rated 1–3) and improved 
quality of life.
Discussion
It was found that the SSO skin patch consistently and 
adequately relieved muscular pain. However, SSO is not 
a topical analgesic, and has been tested on various painful 
medical conditions (such as rotator cuff injuries) without 
success. The SSO skin patch has been successful in relieving 
painful, spasmodic conditions (including those associated 
with smooth muscle) such as those that have been previously 
described. I have theorized that SSO relieves pain by relaxing 
the underlying muscle spasm.
Due to its seemingly preferential action in the relief of 
muscular pain, I investigated the application of the SSO skin 
patch for relief of pain associated with ﬁ  bromyalgia. Patients 
reported a signiﬁ  cant decrease in their pain rating within one 
hour of application.
For relief of headaches, patients were instructed to apply 
the SSO skin patch directly to the back of the neck upon onset 
of pain. Headaches were consistently relieved within one 
hour. Similar results were not achieved with application of 
the patch to other areas of the head or neck, including the 
frontal and temporal regions.
It is of interest that previous trials with the SSO skin 
patch to relieve headaches in patients without concomi-
tant ﬁ  bromyalgia have been unsuccessful. This suggests 
that headaches associated with ﬁ  bromyalgia may have a 
different pathophysiology than those of patients without 
ﬁ  bromyalgia.
Many topical analgesic patches have strong scents. 
However, it is unclear whether these scents contribute to 
the pain-relieving properties of the medications, or are 
simply an inherent chemical characteristic. Scents are 
already used in alternative medicine, and applications such 
as aromatherapy have become increasingly popular, how-
ever, any medicinal beneﬁ  ts remain undocumented (Cook 
and Ernst 2000).
I hypothesize that the active ingredient in the SSO skin 
patch is the scent itself. This would represent a new and 
unique method of medicinal delivery, because the scent is 
seemingly absorbed through the skin and not via the olfactory 
system.
From these results, I conclude that the SSO skin patch 
is a safe and effective topical treatment for the pain of 
ﬁ  bromyalgia.
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